詞庫查詢

查詢 Elsevier TF-IDF 關鍵詞(16,935 詞)與 THU 中文擴充詞庫。想知道自己的研究會命中哪些規則?先查這裡。

Elsevier TF-IDF 詞 16,935 筆

SDG 目標 集合內文獻 Scopus 文獻 佔比 TF-IDF
3 良好健康與福祉 obesity and insulin resistance 3,673 3,890 94% 19.27
3 良好健康與福祉 prostate cancer risk 3,887 4,098 95% 19.27
3 良好健康與福祉 recurrent prostate cancer 1,480 1,550 95% 19.27
3 良好健康與福祉 objective response rate (orr) 3,629 3,847 94% 19.27
3 良好健康與福祉 anti-cancer effects 3,767 3,982 95% 19.27
3 良好健康與福祉 diabetes technology 1,704 1,808 94% 19.27
3 良好健康與福祉 highly pathogenic avian influenza 3,575 3,794 94% 19.27
3 良好健康與福祉 large b cell lymphoma 3,582 3,801 94% 19.27
3 良好健康與福祉 lung cancer surgery 1,906 2,037 94% 19.27
3 良好健康與福祉 hepatitis c virus genotype 1,896 2,026 94% 19.27
3 良好健康與福祉 hepatitis c (hcv) 2,200 2,364 93% 19.27
3 良好健康與福祉 cancer diagnosis and treatment 2,609 2,806 93% 19.27
3 良好健康與福祉 tnbc cells 2,370 2,550 93% 19.27
3 良好健康與福祉 breast cancer resistance protein (bcrp) 1,201 1,224 98% 19.27
3 良好健康與福祉 large b-cell lymphomas 1,525 1,603 95% 19.27
3 良好健康與福祉 pca cells 2,563 2,758 93% 19.27
3 良好健康與福祉 plasma hiv rna 1,284 1,322 97% 19.27
3 良好健康與福祉 curative-intent 1,710 1,816 94% 19.27
3 良好健康與福祉 protumor 1,872 2,000 94% 19.27
3 良好健康與福祉 cancer-related mortality 3,539 3,761 94% 19.27
3 良好健康與福祉 asthma exacerbations 4,165 4,367 95% 19.27
3 良好健康與福祉 braf mutations 2,646 2,847 93% 19.27
3 良好健康與福祉 hiv-1 subtypes 1,404 1,463 96% 19.27
3 良好健康與福祉 clinically localized prostate cancer 2,134 2,293 93% 19.27
3 良好健康與福祉 european organization for research and treatment of cancer 3,853 4,069 95% 19.27
3 良好健康與福祉 b-cell lymphoma 2 2,710 2,915 93% 19.27
3 良好健康與福祉 cardiovascular disease (cvd) risk factors 1,415 1,476 96% 19.27
3 良好健康與福祉 cancer pathogenesis 3,252 3,475 94% 19.27
3 良好健康與福祉 high-grade serous 3,181 3,403 93% 19.27
3 良好健康與福祉 sh-sy5y neuroblastoma 1,889 2,020 94% 19.27
3 良好健康與福祉 environmental and human health 2,130 2,289 93% 19.27
3 良好健康與福祉 cancer diagnostics 3,002 3,220 93% 19.27
3 良好健康與福祉 bladder cancer (bc) 1,943 2,081 93% 19.27
3 良好健康與福祉 cancer resistance 4,218 4,419 95% 19.27
3 良好健康與福祉 advanced non-small cell lung cancer (nsclc) 3,634 3,857 94% 19.27
3 良好健康與福祉 chemoradiation therapy 3,429 3,654 94% 19.27
3 良好健康與福祉 nsclc cell lines 2,704 2,910 93% 19.27
3 良好健康與福祉 circulating tumor dna (ctdna) 2,040 2,190 93% 19.27
3 良好健康與福祉 hepatitis c treatment 1,340 1,389 96% 19.27
3 良好健康與福祉 locally advanced cervical cancer 1,776 1,893 94% 19.27
3 良好健康與福祉 abirateron 2,698 2,904 93% 19.27
3 良好健康與福祉 cancer-associated fibroblasts (cafs) 2,137 2,298 93% 19.27
3 良好健康與福祉 classical hodgkin lymphoma 1,397 1,456 96% 19.27
3 良好健康與福祉 abiraterone 2,693 2,899 93% 19.27
3 良好健康與福祉 anti-cancer therapy 2,897 3,113 93% 19.27
3 良好健康與福祉 nodal staging 1,487 1,561 95% 19.27
3 良好健康與福祉 obesity weight loss 1,621 1,716 94% 19.27
3 良好健康與福祉 art adherence 1,877 2,008 93% 19.27
3 良好健康與福祉 bcr-abl1 2,068 2,222 93% 19.27
3 良好健康與福祉 sustained viral response 1,389 1,447 96% 19.27